Rebecca AraujoPsoriatic Arthritis | April 19, 2024
A study assessed deucravacitinib in patients with active psoriatic arthritis compared with placebo.
Read More
Rebecca AraujoPsoriatic Arthritis | April 17, 2024
Patients with psoriatic arthritis who have enthesitis are more likely to persist on treatment with tofacitinib.
Mithu Maheswaranathan, MDRheumatology | April 12, 2024
A study analyzed the use of after-visit instructions at rheumatology clinics.
Rebecca AraujoPsoriatic Arthritis | April 2, 2024
Treatment with guselkumab provided a durable therapeutic benefit to patients with psoriatic arthritis.
Rebecca AraujoRheumatology | March 25, 2024
Reproductive health outcomes appear to be greatly impacted by the presence of rheumatic diseases.
Rebecca AraujoOsteoarthritis | March 19, 2024
Between 1990 and 2019, the global incidence of early-onset osteoarthritis doubled.
Rebecca AraujoRheumatoid Arthritis | March 19, 2024
The FDA has approved tocilizumab-aazg for the treatment of rheumatoid arthritis, among other diseases.
Rebecca AraujoOsteoarthritis | March 6, 2024
A regimen of nonoperative care prior to surgery for knee osteoarthritis was associated with good adherence.
Mithu Maheswaranathan, MDRheumatoid Arthritis | March 6, 2024
A case series presented data on the efficacy of CAR T-cell treatment in patients with rheumatic autoimmune disease.
Mithu Maheswaranathan, MDOsteoarthritis | February 5, 2024
It is critical for physicians to be confident and comfortable in diagnosing and managing knee osteoarthritis.
Dr. Mark BleackleyRheumatology | February 2, 2024
Incannex announces the first dosing in a phase 2 study of a novel drug combination comprising HCQ and CBD to treat RA.
Rob DillardAI | January 16, 2024
Artificial intelligence can potentially detect rheumatic heart disease with the same level of accuracy as a cardiologist.
Mithu Maheswaranathan, MDRheumatology | December 22, 2023
Mithu Maheswaranathan, MD, spoke about challenges, treatments, and trends in rheumatology, as well as upcoming advancements.
Mithu Maheswaranathan, MDRheumatology | December 6, 2023
A study aimed to create a benefit-versus-harm shared decision-making tool for hydroxychloroquine for patients with SLE.
Rebecca AraujoRheumatoid Arthritis | November 27, 2023
Having multiple risk factors for cardiovascular disease may increase the risk of rheumatoid arthritis treatment failure.
Rebecca AraujoRheumatoid Arthritis | November 9, 2023
Recent safety data significantly impacted prescribing practices for advanced RA therapies among physicians treating veterans.
Rebecca AraujoRheumatology | November 3, 2023
For adults with lupus nephritis, this specific treatment combination improves total remission rate better than others.
Rebecca AraujoRheumatology | October 24, 2023
Bimekizumab demonstrated sustained efficacy for the treatment of active axial spondyloarthritis through 52 weeks.
Mithu Maheswaranathan, MDRheumatology | October 11, 2023
A study provided a unique characterization of a rare: large-vessel involvement from ANCA-associated vasculitis.
Mithu Maheswaranathan, MDRheumatoid Arthritis | October 11, 2023
A study sought to identify variables distinguishing inflammatory from noninflammatory arthritis in a large cohort.
Latest News

April 23, 2024